Nymox's AlzheimAlert available from January:
This article was originally published in Clinica
Nymox's AlzheimAlert urine test will be available in the US from January through HealthScreen America, a subsidiary of HealthScreen International. The test detects levels of a brain protein called neural thread protein that is elevated in patients with Alzheimer's disease. Maywood, New Jersey-based Nymox says its test is the only available, painless, non-invasive peripheral test proven to help in the diagnosis of Alzheimer's.